Abstracts (HTML) List of Authors

Zacherl, Mathias

Immune Modulation in Untreated, Contralateral Hepatic Metastases after Yttrium-90 Radioembolization of Microsatellite Stable Colorectal Cancer

Zarka, Valentina

Therapeutische Sequenzen der systemischen Therapie nach Atezolizumab plus Bevacizumab zur Behandlung des HCC: Eine Real-World-Analyse der IMMUreal-Kohorte

Zehn, Dietmar

Circulating CD8 T cells are sentinels for intrahepatic T cell responses during HBV infection

Zeiser, Robert

Focal Adhesion Kinase (FAK)-Dependent Immune Escape in Hepatocellular Carcinoma

Zeman, Florian

Establishment and Validation of the new LIVERAID-ICU Score for Prognostic Assessment in Patients with Liver Cirrhosis and Infections in the Intensive Care Unit

Zenker, Martin

Genetic Variant Analysis in Low Phospholipid-Associated Cholelithiasis Patients through Whole Exome Sequencing

Zeuzem, Nicholas

Improved Mortality Risk Stratification in Decompensated Liver Cirrhosis and Acute-On-Chronic Liver Failure Using the Updated KDIGO AKI Criteria
Effects of sodium-linked glucose transporter 2 inhibitors in liver transplant recipients with impaired renal function

Zeuzem, Stefan

Improvement in liver histology is observed in most patients with chronic hepatitis delta after 48 weeks of bulevirtide monotherapy

Zhang, Ke

First-in-human Clinical Results of a Novel HBV-specific TCR T Cell Therapy (SCG101) in Patients With HBV-related Hepatocellular Carcinoma (HCC)
Generation and functional analysis of spacer-modified HBV-specific chimeric antigen receptors

Zhang, Liwei

Multi-Omics Gene Signatures Predict Disease Trajectory in a Cholestasis-Based ACLF Mouse Model

Zhang, Mengyin

A DNA launch method for HBV infection in human hepatocyte chimeric mice enables isogenic studies of basal-core promoter and precore mutants

Zhang, Siwen

Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab

Zhang, Tao

Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab

Zhao, Xinlei

Deciphering the Role of LSD1 in Hepatocellular Carcinoma: Implications for Cell Proliferation and Energy Homeostasis

Zheng, Chaowen

Stabilin1 mediates ingestion of oxidized erythrocytes by LSECs (efferocytosis)

Zhipeng, Deng

Dynamics of disease progression and regeneration in a multiscale liver model
Disease stage dependent efficacy of systemic apical sodium dependent bile acid transporter (ASBT) inhibition in mice with cholemic nephropathy

Zhou, Jordi Yang

Angiopoietin-1 Receptor (CD202b) Identifies IL-4-secreting Human Invariant Natural Killer Cells

Zhou, Yichen

A DNA launch method for HBV infection in human hepatocyte chimeric mice enables isogenic studies of basal-core promoter and precore mutants

Zhou, Yuhong

First-in-human Clinical Results of a Novel HBV-specific TCR T Cell Therapy (SCG101) in Patients With HBV-related Hepatocellular Carcinoma (HCC)

Zibert, Andree

Korrektur der Morbus Wilson Punktmutation H1069Q in iPSCs mittels CRISPR/Cas9 Genom-Editierung
High copper levels induce inflammation and oxidative stress in a cell culture model of Wilson's disease

Ziegler, Paul Friedrich

Proteome comparison of pre-neoplastic lesions in different non-cirrhotic models of liver carcinogenesis in mice

Zimmermann, Katharina

Sarcoidosis of the Liver – An underdiagnosed entity
Optimizing Piperacillin/Tazobactam Dosing in ACLF Patients through Interprofessional Therapeutic Drug Monitoring

Zink, Joseph

Mucosal-associated invariant T (MAIT) cells exert direct anti-viral effector function against HBV
Mucosal-associated invariant T (MAIT) cells are functionally impaired and metabolically altered in patients with chronic HBV infection
The anti-tumour effector function of mucosal-associated invariant T cells against hepatocellular carcinoma is impaired by fatty acids and aberrant lipid metabolism
Mucosal-associated invariant T (MAIT) cells possess direct anti-tumour potential, but are rendered dysfunctional within the tumour microenvironment in HCC

Zipprich, Alexander

Influence of low-dose acetylsalicylic acid on renal function in patients with liver cirrhosis and ascites

Zischka, Hans

The anti-tumour effector function of mucosal-associated invariant T cells against hepatocellular carcinoma is impaired by fatty acids and aberrant lipid metabolism

Zizmare, Laimdota

A 5:2 intermittent fasting regimen ameliorates MASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1

Zoller, Heinz

Excessive production and cleavage of fibroblast growth factor 23 in decompensated cirrhosis: pathophysiological and clinical implications
Interaktion zwischen metabolischen Faktoren und Genetik am Beispiel Alpha-1-Antitrypsin-Mangel

Zonouzi, Aysan Poursadegh

Antibiotic-mediated microbiota depletion limits IgA-related fibrogenesis in metabolic dysfunction-associated steatohepatitis

Zuber-Jerger, Ina

Digital single-operator cholangioscopy characterizes distinct phenotypes of primary sclerosing cholangitis

zur Wiesch, Julian Schulze

Duration and clinical relevance of viral shedding of HEV by the stool: results from an observational prospective study
Analysis of HEV infection rates in immunocompetent MPGN patients compared to controls
Expression signatures of IL-18 and IL-18BP characterize stages of cirrhotic decompensation

Zwanziger, Denise

Absence of cholesterol gallstone formation in male C57BL/6 mice by abrogation of hepatic thyroid hormone action
Abrogation of Hepatic TRβ Action Protects the Liver from Acute Liver Injury